A Comparative Evaluation Of Visual Outcomes And Patient Satisfaction Of 2 Trifocal Intraocular Lenses

To compare visual, refractive, and patient-reported outcomes of patients implanted with two designs of trifocal intraocular lenses (IOLs): the Synergy (Johnson & Johnson, USA) and the FineVision (PhysIOL, Belgium).

Ein Tal Eye Center, Tel-Aviv, Israel

164 eyes (64 Synergy, 100 FineVision) of 82 patients who underwent uneventful bilateral cataract surgery with trifocal IOL implantation were retrospectively evaluated. Main outcome measures at 1 month postoperatively included uncorrected and corrected visual acuities at distance (UDVA, CDVA), uncorrected intermediate VA (UIVA), and uncorrected near VA (UNVA), spherical equivalent (SE), and patient-reported outcome measures (PROMs).

Mean SE: Synergy 0.05±0.31D, FineVision -0.06±0.38D. UDVA and UNVA were excellent and similar (Synergy 0.07±0.06, 0.02±0.03; FineVision 0.07±0.06, 0.02±0.04 logMAR, respectively, p>0.05). Synergy had superior UIVA compared to Finevision (0.04±0.04 vs 0.08±0.07 logMAR, respectively p<0.01). Spectacle independence was excellent and similar for distance and intermediate (Synergy 100%, 93.5%, FineVision 94%, 94% respectively, P>0.05) and reasonable for near (80%, 78% respectively, p>0.05). Rate of significant photic phenomena was high and similar (Synergy 40.6%, FineVision 38.0% p>0.05), Nevertheless, only 15.7% and 10% of the patients reported they are disturbed by it in their daily life activities (Synergy and FineVision respectively, p>0.05)

Both IOLs provide excellent visual outcomes, spectacle independence, and patient satisfaction. The Synergy IOL demonstrates superior uncorrected intermediate visual acuity. Both IOLs demonstrated similar high rates of photic phenomena but with high patient tolerance.